)
Vaxart (VXRT) investor relations material
Vaxart Fireside chat summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Introduction and agenda
Management recapped key developments, including partnerships, clinical milestones, and cost management as priorities moving into 2026.
The agenda included a Q&A session with stockholders, focusing on clinical progress, partnerships, and financial strategy.
Background and experience of the speaker
The panel included the CEO, Chief Scientific Officer, Chief Medical Officer, CFO, and General Counsel, each providing insights into their respective areas.
Current industry trends
The vaccine funding environment remains in flux domestically, with increased scrutiny on mRNA vaccines and shifting public sentiment.
Global demand for effective, thermostable, and easy-to-administer vaccines is growing, with major international commitments for immunization funding.
- 2025 revenue hit $237.3M, with profitability and pivotal vaccine trials advancing.VXRT
Q4 202512 Mar 2026 - Oral pill vaccine platform advances with strong clinical progress, partnerships, and 2026 milestones.VXRT
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026 - Oral pill vaccine platform advances with pivotal trials and strong financial runway into 2027.VXRT
Corporate presentation25 Feb 2026 - Secured $453M BARDA contract, strong liquidity, and advanced COVID-19 and norovirus programs.VXRT
Q2 20242 Feb 2026 - Q3 revenue doubled, net loss narrowed, and vaccine programs advanced with BARDA support.VXRT
Q3 202414 Jan 2026 - Oral pill vaccines show promise for broad, convenient immunization, with pivotal trial results due in 2026.VXRT
Global BioInnovation Forum 202613 Jan 2026 - Oral pill vaccine platform shows broad efficacy and strong pipeline, with major milestones ahead.VXRT
Corporate Presentation9 Jan 2026 - Director elections approved, reverse split and say-on-pay failed, partnership talks ongoing.VXRT
AGM 20256 Jan 2026 - Revenue rose to $28.7M as net loss narrowed and vaccine programs advanced amid restructuring.VXRT
Q4 202426 Dec 2025
Next Vaxart earnings date
Next Vaxart earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)